← back to search

Zhiwei Rong

Harbin Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Statistics and Probability
Research interest
Research interests include Ovarian cancer, Computer science, Metabolomics, Medicine, Chemistry, and Oncology.
h-index
citations
590
works
23
NIH funding
primary concept
email

Recent publications

A bidirectional interpretable compound-protein interaction prediction framework based on cross attention
Computers in Biology and Medicine 2024cited by 11position: middledoi
E2EFP-MIL: End-to-end and high-generalizability weakly supervised deep convolutional network for lung cancer classification from whole slide image
Medical Image Analysis 2023cited by 37position: middledoi
MCluster-VAEs: An end-to-end variational deep learning-based clustering method for subtype discovery using multi-omics data
Computers in Biology and Medicine 2022cited by 34position: firstdoi
Improving ovarian cancer treatment decision using a novel risk predictive tool
Aging 2022cited by 13position: middledoi
A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening
Medical Image Analysis 2021cited by 102position: middledoi
WaveICA 2.0: a novel batch effect removal method for untargeted metabolomics data without using batch information
Metabolomics 2021cited by 21position: middledoi
Comparative and quantitative analysis of COVID-19 epidemic interventions in Chinese provinces
Results in Physics 2021cited by 6position: middledoi
NormAE: Deep Adversarial Learning Model to Remove Batch Effects in Liquid Chromatography Mass Spectrometry-Based Metabolomics Data
Analytical Chemistry 2020cited by 65position: firstdoi
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment
Journal of Cellular Biochemistry 2020cited by 15position: middledoi
<p>Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer</p>
Cancer Management and Research 2020cited by 5position: middledoi
Metabolic phenotyping to monitor chronic enteritis canceration
Metabolomics 2020cited by 5position: middledoi
Methylation Biomarkers with Discriminating Ability are Potential Therapeutic Targets in Lung Adenocarcinoma
Epigenomics 2020cited by 1position: middledoi
WaveICA: A novel algorithm to remove batch effects for large-scale untargeted metabolomics data based on wavelet analysis
Analytica Chimica Acta 2019cited by 64position: middledoi
An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade
Journal of Cellular Biochemistry 2019cited by 31position: middledoi
Integrative prognostic subtype discovery in high‐grade serous ovarian cancer
Journal of Cellular Biochemistry 2019cited by 28position: middledoi
Platelet‐derived growth factor‐D expression mediates the effect of differentiated degree on prognosis in epithelial ovarian cancer
Journal of Cellular Biochemistry 2019cited by 6position: middledoi
Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics
Analytical Chemistry 2018cited by 49position: middledoi
Plasma metabolomic profiling distinguishes right-sided from left-sided colon cancer
Clinica Chimica Acta 2018cited by 25position: middledoi
An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
Frontiers in Immunology 2018cited by 9position: middledoi
Single-gene prognostic signatures for advanced stage serous ovarian cancer based on 1257 patient samples
Molecular Omics 2018cited by 0position: middledoi
Identification of pathway‐based recurrence‐associated signatures in optimally debulked patients with serous ovarian cancer
Journal of Cellular Biochemistry 2018cited by 0position: middledoi
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
Scientific Reports 2017cited by 58position: middledoi
Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
Scientific Reports 2017cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kang Li · Kunming University of Science and Technology18 papers (2017–2022)Kui Deng · Nanchang University12 papers (2018–2021)Weiwei Zhao · University of Iowa10 papers (2018–2020)Yan Hou · Merck & Co., Inc., Rahway, NJ, USA (United States)9 papers (2017–2022)Kai Yang · Union Hospital8 papers (2017–2020)Lei Cao · Tianjin First Center Hospital7 papers (2020–2021)Zhenzi Li · Harbin Medical University6 papers (2017–2020)Huan Xu · Harbin Medical University6 papers (2018–2019)Yuqing Cai · Nanjing University of Chinese Medicine5 papers (2018–2019)Chunyan Yang · North Sichuan Medical University5 papers (2019–2020)Hongyu Xie · The University of Western Australia5 papers (2017–2019)Zhenyi Xu · Ministry of Education of the People's Republic of China5 papers (2019–2024)Wei Song · Qingdao University4 papers (2018–2019)Liuchao Zhang · Beijing Institute of Technology4 papers (2020–2024)Yaxin Lu · Sun Yat-sen University4 papers (2019–2020)Wenjie Wang · Xi'an University of Architecture and Technology4 papers (2017–2020)Zheng‐Jiang Zhu · Shanghai University4 papers (2018–2021)Qilong Tan · University of Birmingham3 papers (2019–2020)Yue Huang · Nanjing Medical University3 papers (2019–2020)Yuanyuan Zhang · Zhejiang Chinese Medical University3 papers (2018–2019)